EVOLUTION BIO
Live / Applied — First extension granted (statement of use) (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 12 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98848881
- Mark type
- Stylized text
- Filed
- 12 Nov 2024
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Mixed biological preparations for the prevention and treatment of infectious diseases; therapeutic pharmaceuticals for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, as well as cancer and transplant rejections
- Class 040 — Treatment of materials: Protein engineering services, namely, the recombination of genes customized to the specification of others to produce novel gene sequences for use in science, research, and medicine
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; research and development in the biotechnology field; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; research and development of pharmaceutical preparations and substances for use in clinical trials; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drugs, materials, and molecular development; software as a service (saas) services featuring computer software platforms for use in optimizing drugs, materials, and molecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drugs, materials, and molecular discovery
Owner
- Evolution Bio, Inc., Park City, UT, US
- Evolution Bio, Inc., Park City, UT, US
Prosecution history
- 27 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2026 — SOU EXTENSION 1 GRANTED
- 26 Feb 2026 — SOU EXTENSION 1 FILED
- 26 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Apr 2025 — NON-FINAL ACTION E-MAILED
- 21 Apr 2025 — NON-FINAL ACTION WRITTEN